Methods to produce bunyavirus replicon particles

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9109199
APP PUB NO 20130236493A1
SERIAL NO

13822794

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to methods of producing infectious bunyavirus replicon particles. These bunyavirus replicon particles are safe and can be used outside a biosafety containment. The invention further relates to recombinant bunyavirus replicon particles and uses of these recombinant bunyavirus replicon particles.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
STICHTING WAGENINGEN RESEARCHDROEVENDAALSESTEEG 4 WAGENINGEN 6708 PB

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kortekaas, Jeroen Alexander Zwolle, NL 5 17
Moormann, Robertus Jacobus Maria Dronten, NL 16 297

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 18, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00